nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ABCB1—kidney cancer	0.225	1	CbGaD
Prednisone—ABCB1—Temsirolimus—kidney cancer	0.0494	0.117	CbGbCtD
Prednisone—CYP3A4—Everolimus—kidney cancer	0.0439	0.104	CbGbCtD
Prednisone—ALB—Erlotinib—kidney cancer	0.0354	0.0837	CbGbCtD
Prednisone—CYP3A4—Temsirolimus—kidney cancer	0.0296	0.07	CbGbCtD
Prednisone—ABCB1—Pazopanib—kidney cancer	0.026	0.0614	CbGbCtD
Prednisone—ABCB1—Dactinomycin—kidney cancer	0.0238	0.0561	CbGbCtD
Prednisone—ABCB1—Gemcitabine—kidney cancer	0.0188	0.0444	CbGbCtD
Prednisone—CYP2C19—Sorafenib—kidney cancer	0.0187	0.0441	CbGbCtD
Prednisone—ABCB1—Erlotinib—kidney cancer	0.0185	0.0438	CbGbCtD
Prednisone—ABCB1—Paclitaxel—kidney cancer	0.017	0.0401	CbGbCtD
Prednisone—CYP3A4—Pazopanib—kidney cancer	0.0156	0.0368	CbGbCtD
Prednisone—ABCB1—Sorafenib—kidney cancer	0.0151	0.0356	CbGbCtD
Prednisone—ABCB1—Vinblastine—kidney cancer	0.0149	0.0352	CbGbCtD
Prednisone—ABCB1—Vincristine—kidney cancer	0.0146	0.0346	CbGbCtD
Prednisone—ABCB1—Sunitinib—kidney cancer	0.0122	0.0288	CbGbCtD
Prednisone—CYP3A4—Erlotinib—kidney cancer	0.0111	0.0262	CbGbCtD
Prednisone—CYP3A4—Paclitaxel—kidney cancer	0.0102	0.024	CbGbCtD
Prednisone—ABCB1—Doxorubicin—kidney cancer	0.00914	0.0216	CbGbCtD
Prednisone—CYP3A4—Sorafenib—kidney cancer	0.00903	0.0213	CbGbCtD
Prednisone—CYP3A4—Vinblastine—kidney cancer	0.00892	0.0211	CbGbCtD
Prednisone—CYP3A4—Vincristine—kidney cancer	0.00877	0.0207	CbGbCtD
Prednisone—CYP3A4—Sunitinib—kidney cancer	0.00732	0.0173	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—kidney cancer	0.00548	0.0129	CbGbCtD
Prednisone—HSD11B1—renal system—kidney cancer	0.00411	0.116	CbGeAlD
Prednisone—CYP2C19—urine—kidney cancer	0.00406	0.115	CbGeAlD
Prednisone—HSD11B1—kidney—kidney cancer	0.00397	0.112	CbGeAlD
Prednisone—HSD11B1—cortex of kidney—kidney cancer	0.00387	0.109	CbGeAlD
Prednisone—HSD11B1—gonad—kidney cancer	0.00368	0.104	CbGeAlD
Prednisone—NR3C1—urine—kidney cancer	0.00318	0.0897	CbGeAlD
Prednisone—CYP3A4—urine—kidney cancer	0.0024	0.0678	CbGeAlD
Prednisone—Amcinonide—ANXA1—kidney cancer	0.00146	0.373	CrCbGaD
Prednisone—SLCO1A2—renal system—kidney cancer	0.00124	0.0351	CbGeAlD
Prednisone—SLCO1A2—kidney—kidney cancer	0.0012	0.0339	CbGeAlD
Prednisone—NR3C1—nephron tubule—kidney cancer	0.000855	0.0241	CbGeAlD
Prednisone—NR3C1—renal system—kidney cancer	0.000777	0.0219	CbGeAlD
Prednisone—NR3C1—kidney—kidney cancer	0.000752	0.0212	CbGeAlD
Prednisone—NR3C1—cortex of kidney—kidney cancer	0.000732	0.0207	CbGeAlD
Prednisone—NR3C1—gonad—kidney cancer	0.000697	0.0197	CbGeAlD
Prednisone—NR3C1—cardiac atrium—kidney cancer	0.000696	0.0197	CbGeAlD
Prednisone—Hydrocortisone—ANXA1—kidney cancer	0.000614	0.157	CrCbGaD
Prednisone—CYP3A4—renal system—kidney cancer	0.000588	0.0166	CbGeAlD
Prednisone—CYP3A4—kidney—kidney cancer	0.000568	0.016	CbGeAlD
Prednisone—ABCB1—nephron tubule—kidney cancer	0.000458	0.0129	CbGeAlD
Prednisone—Dexamethasone—ANXA1—kidney cancer	0.000457	0.117	CrCbGaD
Prednisone—ABCB1—renal system—kidney cancer	0.000416	0.0117	CbGeAlD
Prednisone—ABCB1—kidney—kidney cancer	0.000402	0.0114	CbGeAlD
Prednisone—ABCB1—cortex of kidney—kidney cancer	0.000392	0.0111	CbGeAlD
Prednisone—ABCB1—gonad—kidney cancer	0.000373	0.0105	CbGeAlD
Prednisone—Triamcinolone—BCHE—kidney cancer	0.00028	0.0718	CrCbGaD
Prednisone—Clobetasol propionate—CYP1A1—kidney cancer	0.000263	0.0674	CrCbGaD
Prednisone—Methylprednisolone—ABCB1—kidney cancer	0.00013	0.0334	CrCbGaD
Prednisone—Triamcinolone—PTGS2—kidney cancer	0.000129	0.0331	CrCbGaD
Prednisone—Betamethasone—PTGS2—kidney cancer	0.000106	0.0271	CrCbGaD
Prednisone—Dizziness—Erlotinib—kidney cancer	0.000101	0.000419	CcSEcCtD
Prednisone—Ill-defined disorder—Paclitaxel—kidney cancer	0.000101	0.000419	CcSEcCtD
Prednisone—Connective tissue disorder—Capecitabine—kidney cancer	0.0001	0.000418	CcSEcCtD
Prednisone—Vomiting—Everolimus—kidney cancer	0.0001	0.000418	CcSEcCtD
Prednisone—Anaemia—Paclitaxel—kidney cancer	0.0001	0.000417	CcSEcCtD
Prednisone—Paraesthesia—Vincristine—kidney cancer	0.0001	0.000417	CcSEcCtD
Prednisone—Agitation—Paclitaxel—kidney cancer	9.96e-05	0.000415	CcSEcCtD
Prednisone—Rash—Everolimus—kidney cancer	9.94e-05	0.000414	CcSEcCtD
Prednisone—Dermatitis—Everolimus—kidney cancer	9.93e-05	0.000414	CcSEcCtD
Prednisone—Headache—Vinblastine—kidney cancer	9.91e-05	0.000413	CcSEcCtD
Prednisone—Angioedema—Paclitaxel—kidney cancer	9.9e-05	0.000413	CcSEcCtD
Prednisone—Purpura—Doxorubicin—kidney cancer	9.88e-05	0.000411	CcSEcCtD
Prednisone—Headache—Everolimus—kidney cancer	9.88e-05	0.000411	CcSEcCtD
Prednisone—Body temperature increased—Dactinomycin—kidney cancer	9.85e-05	0.00041	CcSEcCtD
Prednisone—Abdominal pain—Dactinomycin—kidney cancer	9.85e-05	0.00041	CcSEcCtD
Prednisone—Dexamethasone—CYP1A1—kidney cancer	9.83e-05	0.0252	CrCbGaD
Prednisone—Asthenia—Sorafenib—kidney cancer	9.82e-05	0.000409	CcSEcCtD
Prednisone—Malaise—Paclitaxel—kidney cancer	9.77e-05	0.000407	CcSEcCtD
Prednisone—Cardiac failure—Doxorubicin—kidney cancer	9.76e-05	0.000406	CcSEcCtD
Prednisone—Vertigo—Paclitaxel—kidney cancer	9.74e-05	0.000406	CcSEcCtD
Prednisone—Syncope—Paclitaxel—kidney cancer	9.72e-05	0.000405	CcSEcCtD
Prednisone—Lethargy—Doxorubicin—kidney cancer	9.72e-05	0.000405	CcSEcCtD
Prednisone—Hypersensitivity—Sunitinib—kidney cancer	9.7e-05	0.000404	CcSEcCtD
Prednisone—Decreased appetite—Vincristine—kidney cancer	9.68e-05	0.000403	CcSEcCtD
Prednisone—Pruritus—Sorafenib—kidney cancer	9.68e-05	0.000403	CcSEcCtD
Prednisone—Vomiting—Erlotinib—kidney cancer	9.67e-05	0.000403	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	9.63e-05	0.000401	CcSEcCtD
Prednisone—Fatigue—Vincristine—kidney cancer	9.6e-05	0.0004	CcSEcCtD
Prednisone—Rash—Erlotinib—kidney cancer	9.59e-05	0.000399	CcSEcCtD
Prednisone—Dermatitis—Erlotinib—kidney cancer	9.58e-05	0.000399	CcSEcCtD
Prednisone—Insomnia—Gemcitabine—kidney cancer	9.56e-05	0.000398	CcSEcCtD
Prednisone—Eye disorder—Capecitabine—kidney cancer	9.55e-05	0.000398	CcSEcCtD
Prednisone—Headache—Erlotinib—kidney cancer	9.53e-05	0.000397	CcSEcCtD
Prednisone—Loss of consciousness—Paclitaxel—kidney cancer	9.53e-05	0.000397	CcSEcCtD
Prednisone—Constipation—Vincristine—kidney cancer	9.52e-05	0.000397	CcSEcCtD
Prednisone—Osteoarthritis—Doxorubicin—kidney cancer	9.52e-05	0.000397	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	9.52e-05	0.000397	CcSEcCtD
Prednisone—Paraesthesia—Gemcitabine—kidney cancer	9.49e-05	0.000395	CcSEcCtD
Prednisone—Flushing—Capecitabine—kidney cancer	9.48e-05	0.000395	CcSEcCtD
Prednisone—Asthenia—Sunitinib—kidney cancer	9.45e-05	0.000394	CcSEcCtD
Prednisone—Nausea—Vinblastine—kidney cancer	9.4e-05	0.000392	CcSEcCtD
Prednisone—Convulsion—Paclitaxel—kidney cancer	9.39e-05	0.000391	CcSEcCtD
Prednisone—Affect lability—Doxorubicin—kidney cancer	9.37e-05	0.00039	CcSEcCtD
Prednisone—Nausea—Everolimus—kidney cancer	9.36e-05	0.00039	CcSEcCtD
Prednisone—Diarrhoea—Sorafenib—kidney cancer	9.36e-05	0.00039	CcSEcCtD
Prednisone—Hypertension—Paclitaxel—kidney cancer	9.36e-05	0.00039	CcSEcCtD
Prednisone—Pruritus—Sunitinib—kidney cancer	9.32e-05	0.000388	CcSEcCtD
Prednisone—Angiopathy—Capecitabine—kidney cancer	9.27e-05	0.000386	CcSEcCtD
Prednisone—Immune system disorder—Capecitabine—kidney cancer	9.23e-05	0.000384	CcSEcCtD
Prednisone—Arthralgia—Paclitaxel—kidney cancer	9.23e-05	0.000384	CcSEcCtD
Prednisone—Myalgia—Paclitaxel—kidney cancer	9.23e-05	0.000384	CcSEcCtD
Prednisone—Anxiety—Paclitaxel—kidney cancer	9.2e-05	0.000383	CcSEcCtD
Prednisone—Face oedema—Doxorubicin—kidney cancer	9.19e-05	0.000383	CcSEcCtD
Prednisone—Decreased appetite—Gemcitabine—kidney cancer	9.18e-05	0.000383	CcSEcCtD
Prednisone—Hypersensitivity—Dactinomycin—kidney cancer	9.18e-05	0.000383	CcSEcCtD
Prednisone—Prednisolone—ABCB1—kidney cancer	9.16e-05	0.0235	CrCbGaD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	9.16e-05	0.000382	CcSEcCtD
Prednisone—Arrhythmia—Capecitabine—kidney cancer	9.13e-05	0.00038	CcSEcCtD
Prednisone—Discomfort—Paclitaxel—kidney cancer	9.12e-05	0.00038	CcSEcCtD
Prednisone—Fatigue—Gemcitabine—kidney cancer	9.11e-05	0.000379	CcSEcCtD
Prednisone—Gastrointestinal pain—Vincristine—kidney cancer	9.11e-05	0.000379	CcSEcCtD
Prednisone—Cardiac arrest—Doxorubicin—kidney cancer	9.05e-05	0.000377	CcSEcCtD
Prednisone—Dizziness—Sorafenib—kidney cancer	9.05e-05	0.000377	CcSEcCtD
Prednisone—Constipation—Gemcitabine—kidney cancer	9.03e-05	0.000376	CcSEcCtD
Prednisone—Nausea—Erlotinib—kidney cancer	9.03e-05	0.000376	CcSEcCtD
Prednisone—Alopecia—Capecitabine—kidney cancer	9.03e-05	0.000376	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—kidney cancer	9.02e-05	0.000376	CcSEcCtD
Prednisone—Diarrhoea—Sunitinib—kidney cancer	9.01e-05	0.000375	CcSEcCtD
Prednisone—Betamethasone—ABCB1—kidney cancer	8.98e-05	0.023	CrCbGaD
Prednisone—Mental disorder—Capecitabine—kidney cancer	8.95e-05	0.000373	CcSEcCtD
Prednisone—Asthenia—Dactinomycin—kidney cancer	8.94e-05	0.000373	CcSEcCtD
Prednisone—Erythema—Capecitabine—kidney cancer	8.89e-05	0.000371	CcSEcCtD
Prednisone—Malnutrition—Capecitabine—kidney cancer	8.89e-05	0.000371	CcSEcCtD
Prednisone—Anaphylactic shock—Paclitaxel—kidney cancer	8.85e-05	0.000368	CcSEcCtD
Prednisone—Oedema—Paclitaxel—kidney cancer	8.85e-05	0.000368	CcSEcCtD
Prednisone—Abdominal pain—Vincristine—kidney cancer	8.8e-05	0.000367	CcSEcCtD
Prednisone—Body temperature increased—Vincristine—kidney cancer	8.8e-05	0.000367	CcSEcCtD
Prednisone—Infection—Paclitaxel—kidney cancer	8.79e-05	0.000366	CcSEcCtD
Prednisone—Dry skin—Doxorubicin—kidney cancer	8.73e-05	0.000364	CcSEcCtD
Prednisone—Dizziness—Sunitinib—kidney cancer	8.71e-05	0.000363	CcSEcCtD
Prednisone—Feeling abnormal—Gemcitabine—kidney cancer	8.71e-05	0.000363	CcSEcCtD
Prednisone—Shock—Paclitaxel—kidney cancer	8.7e-05	0.000363	CcSEcCtD
Prednisone—Vomiting—Sorafenib—kidney cancer	8.7e-05	0.000362	CcSEcCtD
Prednisone—Nervous system disorder—Paclitaxel—kidney cancer	8.67e-05	0.000361	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—kidney cancer	8.66e-05	0.000361	CcSEcCtD
Prednisone—Tachycardia—Paclitaxel—kidney cancer	8.63e-05	0.00036	CcSEcCtD
Prednisone—Rash—Sorafenib—kidney cancer	8.63e-05	0.000359	CcSEcCtD
Prednisone—Dermatitis—Sorafenib—kidney cancer	8.62e-05	0.000359	CcSEcCtD
Prednisone—Skin disorder—Paclitaxel—kidney cancer	8.59e-05	0.000358	CcSEcCtD
Prednisone—Headache—Sorafenib—kidney cancer	8.57e-05	0.000357	CcSEcCtD
Prednisone—Hyperhidrosis—Paclitaxel—kidney cancer	8.55e-05	0.000356	CcSEcCtD
Prednisone—Diarrhoea—Dactinomycin—kidney cancer	8.53e-05	0.000355	CcSEcCtD
Prednisone—Anorexia—Paclitaxel—kidney cancer	8.43e-05	0.000351	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—kidney cancer	8.4e-05	0.00035	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	8.4e-05	0.00035	CcSEcCtD
Prednisone—Vision blurred—Capecitabine—kidney cancer	8.38e-05	0.000349	CcSEcCtD
Prednisone—Vomiting—Sunitinib—kidney cancer	8.37e-05	0.000349	CcSEcCtD
Prednisone—Body temperature increased—Gemcitabine—kidney cancer	8.35e-05	0.000348	CcSEcCtD
Prednisone—Rash—Sunitinib—kidney cancer	8.3e-05	0.000346	CcSEcCtD
Prednisone—Dermatitis—Sunitinib—kidney cancer	8.29e-05	0.000346	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—kidney cancer	8.28e-05	0.000345	CcSEcCtD
Prednisone—Ill-defined disorder—Capecitabine—kidney cancer	8.25e-05	0.000344	CcSEcCtD
Prednisone—Headache—Sunitinib—kidney cancer	8.25e-05	0.000344	CcSEcCtD
Prednisone—Anaemia—Capecitabine—kidney cancer	8.22e-05	0.000342	CcSEcCtD
Prednisone—Hypersensitivity—Vincristine—kidney cancer	8.21e-05	0.000342	CcSEcCtD
Prednisone—Nausea—Sorafenib—kidney cancer	8.13e-05	0.000339	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—kidney cancer	8.07e-05	0.000336	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	8.06e-05	0.000336	CcSEcCtD
Prednisone—Malaise—Capecitabine—kidney cancer	8.02e-05	0.000334	CcSEcCtD
Prednisone—Insomnia—Paclitaxel—kidney cancer	8e-05	0.000333	CcSEcCtD
Prednisone—Vertigo—Capecitabine—kidney cancer	7.99e-05	0.000333	CcSEcCtD
Prednisone—Asthenia—Vincristine—kidney cancer	7.99e-05	0.000333	CcSEcCtD
Prednisone—Syncope—Capecitabine—kidney cancer	7.98e-05	0.000332	CcSEcCtD
Prednisone—Paraesthesia—Paclitaxel—kidney cancer	7.94e-05	0.000331	CcSEcCtD
Prednisone—Vomiting—Dactinomycin—kidney cancer	7.93e-05	0.00033	CcSEcCtD
Prednisone—Rash—Dactinomycin—kidney cancer	7.86e-05	0.000327	CcSEcCtD
Prednisone—Nausea—Sunitinib—kidney cancer	7.82e-05	0.000326	CcSEcCtD
Prednisone—Loss of consciousness—Capecitabine—kidney cancer	7.82e-05	0.000326	CcSEcCtD
Prednisone—Dyspepsia—Paclitaxel—kidney cancer	7.79e-05	0.000324	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—kidney cancer	7.69e-05	0.000321	CcSEcCtD
Prednisone—Decreased appetite—Paclitaxel—kidney cancer	7.69e-05	0.00032	CcSEcCtD
Prednisone—Hypertension—Capecitabine—kidney cancer	7.68e-05	0.00032	CcSEcCtD
Prednisone—Fatigue—Paclitaxel—kidney cancer	7.63e-05	0.000318	CcSEcCtD
Prednisone—Diarrhoea—Vincristine—kidney cancer	7.62e-05	0.000317	CcSEcCtD
Prednisone—Asthenia—Gemcitabine—kidney cancer	7.58e-05	0.000316	CcSEcCtD
Prednisone—Arthralgia—Capecitabine—kidney cancer	7.57e-05	0.000315	CcSEcCtD
Prednisone—Myalgia—Capecitabine—kidney cancer	7.57e-05	0.000315	CcSEcCtD
Prednisone—Constipation—Paclitaxel—kidney cancer	7.56e-05	0.000315	CcSEcCtD
Prednisone—Anxiety—Capecitabine—kidney cancer	7.55e-05	0.000314	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	7.52e-05	0.000313	CcSEcCtD
Prednisone—Weight increased—Doxorubicin—kidney cancer	7.49e-05	0.000312	CcSEcCtD
Prednisone—Discomfort—Capecitabine—kidney cancer	7.48e-05	0.000312	CcSEcCtD
Prednisone—Pruritus—Gemcitabine—kidney cancer	7.48e-05	0.000311	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—kidney cancer	7.44e-05	0.00031	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—kidney cancer	7.42e-05	0.000309	CcSEcCtD
Prednisone—Nausea—Dactinomycin—kidney cancer	7.4e-05	0.000308	CcSEcCtD
Prednisone—Dizziness—Vincristine—kidney cancer	7.36e-05	0.000307	CcSEcCtD
Prednisone—Feeling abnormal—Paclitaxel—kidney cancer	7.29e-05	0.000304	CcSEcCtD
Prednisone—Oedema—Capecitabine—kidney cancer	7.26e-05	0.000302	CcSEcCtD
Prednisone—Gastrointestinal pain—Paclitaxel—kidney cancer	7.23e-05	0.000301	CcSEcCtD
Prednisone—Diarrhoea—Gemcitabine—kidney cancer	7.23e-05	0.000301	CcSEcCtD
Prednisone—Infection—Capecitabine—kidney cancer	7.21e-05	0.0003	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—kidney cancer	7.19e-05	0.0003	CcSEcCtD
Prednisone—Shock—Capecitabine—kidney cancer	7.14e-05	0.000297	CcSEcCtD
Prednisone—Nervous system disorder—Capecitabine—kidney cancer	7.12e-05	0.000297	CcSEcCtD
Prednisone—Tachycardia—Capecitabine—kidney cancer	7.08e-05	0.000295	CcSEcCtD
Prednisone—Vomiting—Vincristine—kidney cancer	7.08e-05	0.000295	CcSEcCtD
Prednisone—Skin disorder—Capecitabine—kidney cancer	7.05e-05	0.000294	CcSEcCtD
Prednisone—Urticaria—Paclitaxel—kidney cancer	7.03e-05	0.000293	CcSEcCtD
Prednisone—Rash—Vincristine—kidney cancer	7.02e-05	0.000293	CcSEcCtD
Prednisone—Hyperhidrosis—Capecitabine—kidney cancer	7.02e-05	0.000292	CcSEcCtD
Prednisone—Dermatitis—Vincristine—kidney cancer	7.02e-05	0.000292	CcSEcCtD
Prednisone—Hydrocortisone—ABCB1—kidney cancer	7.01e-05	0.018	CrCbGaD
Prednisone—Body temperature increased—Paclitaxel—kidney cancer	6.99e-05	0.000291	CcSEcCtD
Prednisone—Abdominal pain—Paclitaxel—kidney cancer	6.99e-05	0.000291	CcSEcCtD
Prednisone—Headache—Vincristine—kidney cancer	6.98e-05	0.000291	CcSEcCtD
Prednisone—Anorexia—Capecitabine—kidney cancer	6.92e-05	0.000288	CcSEcCtD
Prednisone—Vomiting—Gemcitabine—kidney cancer	6.72e-05	0.00028	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—kidney cancer	6.71e-05	0.000279	CcSEcCtD
Prednisone—Rash—Gemcitabine—kidney cancer	6.66e-05	0.000277	CcSEcCtD
Prednisone—Dermatitis—Gemcitabine—kidney cancer	6.66e-05	0.000277	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—kidney cancer	6.62e-05	0.000276	CcSEcCtD
Prednisone—Headache—Gemcitabine—kidney cancer	6.62e-05	0.000276	CcSEcCtD
Prednisone—Nausea—Vincristine—kidney cancer	6.62e-05	0.000276	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Capecitabine—kidney cancer	6.61e-05	0.000275	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—kidney cancer	6.59e-05	0.000274	CcSEcCtD
Prednisone—Insomnia—Capecitabine—kidney cancer	6.57e-05	0.000273	CcSEcCtD
Prednisone—Paraesthesia—Capecitabine—kidney cancer	6.52e-05	0.000272	CcSEcCtD
Prednisone—Hypersensitivity—Paclitaxel—kidney cancer	6.52e-05	0.000271	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—kidney cancer	6.47e-05	0.00027	CcSEcCtD
Prednisone—Dyspepsia—Capecitabine—kidney cancer	6.39e-05	0.000266	CcSEcCtD
Prednisone—Asthenia—Paclitaxel—kidney cancer	6.35e-05	0.000264	CcSEcCtD
Prednisone—Decreased appetite—Capecitabine—kidney cancer	6.31e-05	0.000263	CcSEcCtD
Prednisone—Nausea—Gemcitabine—kidney cancer	6.28e-05	0.000261	CcSEcCtD
Prednisone—Fatigue—Capecitabine—kidney cancer	6.26e-05	0.000261	CcSEcCtD
Prednisone—Pruritus—Paclitaxel—kidney cancer	6.26e-05	0.000261	CcSEcCtD
Prednisone—Constipation—Capecitabine—kidney cancer	6.21e-05	0.000259	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—kidney cancer	6.16e-05	0.000256	CcSEcCtD
Prednisone—Dexamethasone—PTGS2—kidney cancer	6.14e-05	0.0158	CrCbGaD
Prednisone—Flushing—Doxorubicin—kidney cancer	6.11e-05	0.000255	CcSEcCtD
Prednisone—Diarrhoea—Paclitaxel—kidney cancer	6.05e-05	0.000252	CcSEcCtD
Prednisone—Feeling abnormal—Capecitabine—kidney cancer	5.98e-05	0.000249	CcSEcCtD
Prednisone—Angiopathy—Doxorubicin—kidney cancer	5.98e-05	0.000249	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—kidney cancer	5.95e-05	0.000248	CcSEcCtD
Prednisone—Gastrointestinal pain—Capecitabine—kidney cancer	5.94e-05	0.000247	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—kidney cancer	5.88e-05	0.000245	CcSEcCtD
Prednisone—Dizziness—Paclitaxel—kidney cancer	5.85e-05	0.000244	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—kidney cancer	5.82e-05	0.000242	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—kidney cancer	5.77e-05	0.00024	CcSEcCtD
Prednisone—Urticaria—Capecitabine—kidney cancer	5.77e-05	0.00024	CcSEcCtD
Prednisone—Body temperature increased—Capecitabine—kidney cancer	5.74e-05	0.000239	CcSEcCtD
Prednisone—Abdominal pain—Capecitabine—kidney cancer	5.74e-05	0.000239	CcSEcCtD
Prednisone—Erythema—Doxorubicin—kidney cancer	5.73e-05	0.000239	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—kidney cancer	5.73e-05	0.000239	CcSEcCtD
Prednisone—Vomiting—Paclitaxel—kidney cancer	5.62e-05	0.000234	CcSEcCtD
Prednisone—Rash—Paclitaxel—kidney cancer	5.58e-05	0.000232	CcSEcCtD
Prednisone—Dermatitis—Paclitaxel—kidney cancer	5.57e-05	0.000232	CcSEcCtD
Prednisone—Headache—Paclitaxel—kidney cancer	5.54e-05	0.000231	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—kidney cancer	5.4e-05	0.000225	CcSEcCtD
Prednisone—Hypersensitivity—Capecitabine—kidney cancer	5.35e-05	0.000223	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—kidney cancer	5.32e-05	0.000222	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—kidney cancer	5.3e-05	0.000221	CcSEcCtD
Prednisone—Agitation—Doxorubicin—kidney cancer	5.27e-05	0.000219	CcSEcCtD
Prednisone—Nausea—Paclitaxel—kidney cancer	5.25e-05	0.000219	CcSEcCtD
Prednisone—Dexamethasone—ABCB1—kidney cancer	5.22e-05	0.0134	CrCbGaD
Prednisone—Asthenia—Capecitabine—kidney cancer	5.21e-05	0.000217	CcSEcCtD
Prednisone—Malaise—Doxorubicin—kidney cancer	5.17e-05	0.000215	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—kidney cancer	5.15e-05	0.000215	CcSEcCtD
Prednisone—Syncope—Doxorubicin—kidney cancer	5.14e-05	0.000214	CcSEcCtD
Prednisone—Pruritus—Capecitabine—kidney cancer	5.14e-05	0.000214	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—kidney cancer	5.04e-05	0.00021	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—kidney cancer	4.97e-05	0.000207	CcSEcCtD
Prednisone—Diarrhoea—Capecitabine—kidney cancer	4.97e-05	0.000207	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—kidney cancer	4.95e-05	0.000206	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—kidney cancer	4.88e-05	0.000203	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—kidney cancer	4.88e-05	0.000203	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—kidney cancer	4.86e-05	0.000203	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.85e-05	0.000202	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—kidney cancer	4.82e-05	0.000201	CcSEcCtD
Prednisone—Dizziness—Capecitabine—kidney cancer	4.8e-05	0.0002	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—kidney cancer	4.68e-05	0.000195	CcSEcCtD
Prednisone—Oedema—Doxorubicin—kidney cancer	4.68e-05	0.000195	CcSEcCtD
Prednisone—Infection—Doxorubicin—kidney cancer	4.65e-05	0.000194	CcSEcCtD
Prednisone—Vomiting—Capecitabine—kidney cancer	4.62e-05	0.000192	CcSEcCtD
Prednisone—Shock—Doxorubicin—kidney cancer	4.6e-05	0.000192	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—kidney cancer	4.59e-05	0.000191	CcSEcCtD
Prednisone—Rash—Capecitabine—kidney cancer	4.58e-05	0.000191	CcSEcCtD
Prednisone—Dermatitis—Capecitabine—kidney cancer	4.57e-05	0.00019	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—kidney cancer	4.57e-05	0.00019	CcSEcCtD
Prednisone—Headache—Capecitabine—kidney cancer	4.55e-05	0.000189	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—kidney cancer	4.55e-05	0.000189	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—kidney cancer	4.52e-05	0.000188	CcSEcCtD
Prednisone—Anorexia—Doxorubicin—kidney cancer	4.46e-05	0.000186	CcSEcCtD
Prednisone—Nausea—Capecitabine—kidney cancer	4.31e-05	0.00018	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.26e-05	0.000178	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—kidney cancer	4.23e-05	0.000176	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—kidney cancer	4.2e-05	0.000175	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—kidney cancer	4.12e-05	0.000172	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—kidney cancer	4.07e-05	0.000169	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—kidney cancer	4.03e-05	0.000168	CcSEcCtD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	4.03e-05	0.000556	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	4.03e-05	0.000556	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—VEGFA—kidney cancer	4.03e-05	0.000556	CbGpPWpGaD
Prednisone—Constipation—Doxorubicin—kidney cancer	4e-05	0.000167	CcSEcCtD
Prednisone—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.91e-05	0.000539	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	3.87e-05	0.000533	CbGpPWpGaD
Prednisone—Feeling abnormal—Doxorubicin—kidney cancer	3.86e-05	0.000161	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.86e-05	0.000532	CbGpPWpGaD
Prednisone—ALB—Hemostasis—GRB7—kidney cancer	3.85e-05	0.00053	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	3.84e-05	0.00053	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Doxorubicin—kidney cancer	3.83e-05	0.000159	CcSEcCtD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.79e-05	0.000523	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CA9—kidney cancer	3.75e-05	0.000517	CbGpPWpGaD
Prednisone—Urticaria—Doxorubicin—kidney cancer	3.72e-05	0.000155	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—kidney cancer	3.7e-05	0.000154	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—kidney cancer	3.7e-05	0.000154	CcSEcCtD
Prednisone—CYP2C19—Metabolism—ACY1—kidney cancer	3.69e-05	0.000508	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.67e-05	0.000506	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ACY1—kidney cancer	3.6e-05	0.000496	CbGpPWpGaD
Prednisone—ALB—Hemostasis—ITPR2—kidney cancer	3.57e-05	0.000493	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—VEGFA—kidney cancer	3.57e-05	0.000492	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—kidney cancer	3.55e-05	0.00049	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.54e-05	0.000488	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.5e-05	0.000483	CbGpPWpGaD
Prednisone—ALB—Metabolism—PDHB—kidney cancer	3.49e-05	0.000481	CbGpPWpGaD
Prednisone—Hypersensitivity—Doxorubicin—kidney cancer	3.45e-05	0.000144	CcSEcCtD
Prednisone—NR3C1—Gene Expression—RPL14—kidney cancer	3.36e-05	0.000464	CbGpPWpGaD
Prednisone—Asthenia—Doxorubicin—kidney cancer	3.36e-05	0.00014	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—kidney cancer	3.31e-05	0.000138	CcSEcCtD
Prednisone—HSD11B1—Metabolism—PIK3CA—kidney cancer	3.28e-05	0.000453	CbGpPWpGaD
Prednisone—ALB—Metabolism—CCBL1—kidney cancer	3.28e-05	0.000453	CbGpPWpGaD
Prednisone—Diarrhoea—Doxorubicin—kidney cancer	3.2e-05	0.000133	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—CRABP1—kidney cancer	3.19e-05	0.00044	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.14e-05	0.000433	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PDHB—kidney cancer	3.13e-05	0.000432	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—POMC—kidney cancer	3.12e-05	0.000431	CbGpPWpGaD
Prednisone—Dizziness—Doxorubicin—kidney cancer	3.09e-05	0.000129	CcSEcCtD
Prednisone—ABCB1—Metabolism—PDHB—kidney cancer	3.06e-05	0.000422	CbGpPWpGaD
Prednisone—Vomiting—Doxorubicin—kidney cancer	2.98e-05	0.000124	CcSEcCtD
Prednisone—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.97e-05	0.000409	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ITPR2—kidney cancer	2.97e-05	0.000409	CbGpPWpGaD
Prednisone—Rash—Doxorubicin—kidney cancer	2.95e-05	0.000123	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—kidney cancer	2.95e-05	0.000123	CcSEcCtD
Prednisone—CYP2C19—Metabolism—CCBL1—kidney cancer	2.95e-05	0.000406	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.95e-05	0.000406	CbGpPWpGaD
Prednisone—Headache—Doxorubicin—kidney cancer	2.93e-05	0.000122	CcSEcCtD
Prednisone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.89e-05	0.000399	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CCBL1—kidney cancer	2.88e-05	0.000396	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.85e-05	0.000393	CbGpPWpGaD
Prednisone—ALB—Metabolism—GLIPR1—kidney cancer	2.85e-05	0.000392	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPAT—kidney cancer	2.85e-05	0.000392	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.81e-05	0.000387	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.78e-05	0.000383	CbGpPWpGaD
Prednisone—Nausea—Doxorubicin—kidney cancer	2.78e-05	0.000116	CcSEcCtD
Prednisone—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	2.74e-05	0.000378	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HSPB1—kidney cancer	2.74e-05	0.000378	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.73e-05	0.000377	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTT1—kidney cancer	2.71e-05	0.000373	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ACHE—kidney cancer	2.71e-05	0.000373	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.66e-05	0.000367	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.66e-05	0.000366	CbGpPWpGaD
Prednisone—ALB—Metabolism—APRT—kidney cancer	2.65e-05	0.000365	CbGpPWpGaD
Prednisone—ALB—Metabolism—FH—kidney cancer	2.65e-05	0.000365	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNA1—kidney cancer	2.62e-05	0.000362	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.62e-05	0.000361	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.59e-05	0.000357	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SCARB1—kidney cancer	2.56e-05	0.000353	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.55e-05	0.000352	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPAT—kidney cancer	2.55e-05	0.000352	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PSMD7—kidney cancer	2.55e-05	0.000351	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS1—kidney cancer	2.53e-05	0.00035	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.52e-05	0.000348	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.52e-05	0.000347	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.5e-05	0.000344	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GLIPR1—kidney cancer	2.49e-05	0.000344	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPAT—kidney cancer	2.49e-05	0.000344	CbGpPWpGaD
Prednisone—ALB—Metabolism—GPC3—kidney cancer	2.49e-05	0.000343	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PSMD7—kidney cancer	2.49e-05	0.000343	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.48e-05	0.000343	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNA2—kidney cancer	2.44e-05	0.000337	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.43e-05	0.000335	CbGpPWpGaD
Prednisone—ALB—Metabolism—CA2—kidney cancer	2.42e-05	0.000334	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—FH—kidney cancer	2.37e-05	0.000327	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—APRT—kidney cancer	2.37e-05	0.000327	CbGpPWpGaD
Prednisone—ALB—Metabolism—ALAD—kidney cancer	2.36e-05	0.000325	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—BCHE—kidney cancer	2.36e-05	0.000325	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	2.35e-05	0.000324	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.35e-05	0.000323	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC5A5—kidney cancer	2.33e-05	0.000321	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.32e-05	0.00032	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—FH—kidney cancer	2.32e-05	0.00032	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—APRT—kidney cancer	2.32e-05	0.00032	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.31e-05	0.000319	CbGpPWpGaD
Prednisone—ALB—Metabolism—ST3GAL2—kidney cancer	2.3e-05	0.000317	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—JUNB—kidney cancer	2.29e-05	0.000315	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.29e-05	0.000315	CbGpPWpGaD
Prednisone—ALB—Metabolism—ALDH1A1—kidney cancer	2.25e-05	0.00031	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC2A1—kidney cancer	2.25e-05	0.00031	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.24e-05	0.000308	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GPC3—kidney cancer	2.23e-05	0.000308	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ACY1—kidney cancer	2.22e-05	0.000306	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IGF2—kidney cancer	2.2e-05	0.000303	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.18e-05	0.000301	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GPC3—kidney cancer	2.18e-05	0.0003	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CA2—kidney cancer	2.17e-05	0.000299	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC5A3—kidney cancer	2.16e-05	0.000297	CbGpPWpGaD
Prednisone—ALB—Metabolism—PGK1—kidney cancer	2.16e-05	0.000297	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.14e-05	0.000296	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.13e-05	0.000293	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CA2—kidney cancer	2.12e-05	0.000292	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.12e-05	0.000292	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALAD—kidney cancer	2.12e-05	0.000292	CbGpPWpGaD
Prednisone—ALB—Metabolism—LDHB—kidney cancer	2.11e-05	0.000292	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.1e-05	0.00029	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.07e-05	0.000285	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALAD—kidney cancer	2.07e-05	0.000285	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.05e-05	0.000283	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.02e-05	0.000279	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.02e-05	0.000278	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ST3GAL2—kidney cancer	2.02e-05	0.000278	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.02e-05	0.000278	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2e-05	0.000276	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.97e-05	0.000272	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.95e-05	0.000269	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PGK1—kidney cancer	1.94e-05	0.000267	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.94e-05	0.000267	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.9e-05	0.000262	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—LDHB—kidney cancer	1.9e-05	0.000262	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC5A3—kidney cancer	1.89e-05	0.000261	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PGK1—kidney cancer	1.89e-05	0.000261	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PDHB—kidney cancer	1.88e-05	0.00026	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—POMC—kidney cancer	1.88e-05	0.000259	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTP1—kidney cancer	1.88e-05	0.000259	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CDKN2B—kidney cancer	1.86e-05	0.000257	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—LDHB—kidney cancer	1.85e-05	0.000255	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.85e-05	0.000255	CbGpPWpGaD
Prednisone—ALB—Metabolism—CA9—kidney cancer	1.83e-05	0.000253	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.79e-05	0.000247	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.79e-05	0.000247	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ABCB1—kidney cancer	1.77e-05	0.000245	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.77e-05	0.000244	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.76e-05	0.000243	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTM1—kidney cancer	1.72e-05	0.000238	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.69e-05	0.000233	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.67e-05	0.00023	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CA9—kidney cancer	1.65e-05	0.000227	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP1A1—kidney cancer	1.63e-05	0.000225	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.62e-05	0.000223	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.61e-05	0.000222	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.61e-05	0.000222	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CA9—kidney cancer	1.61e-05	0.000222	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.59e-05	0.000219	CbGpPWpGaD
Prednisone—ALB—Metabolism—CRABP1—kidney cancer	1.56e-05	0.000215	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPAT—kidney cancer	1.54e-05	0.000212	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.54e-05	0.000212	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	1.5e-05	0.000207	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.5e-05	0.000206	CbGpPWpGaD
Prednisone—ALB—Metabolism—ITPR2—kidney cancer	1.45e-05	0.0002	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—APRT—kidney cancer	1.43e-05	0.000197	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—FH—kidney cancer	1.43e-05	0.000197	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CRABP1—kidney cancer	1.4e-05	0.000193	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.4e-05	0.000193	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.38e-05	0.00019	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CRABP1—kidney cancer	1.37e-05	0.000188	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GPC3—kidney cancer	1.34e-05	0.000185	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.34e-05	0.000185	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.34e-05	0.000184	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.33e-05	0.000184	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTT1—kidney cancer	1.32e-05	0.000182	CbGpPWpGaD
Prednisone—ALB—Metabolism—ACHE—kidney cancer	1.32e-05	0.000182	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CA2—kidney cancer	1.31e-05	0.00018	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ITPR2—kidney cancer	1.3e-05	0.000179	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALAD—kidney cancer	1.27e-05	0.000175	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ITPR2—kidney cancer	1.27e-05	0.000175	CbGpPWpGaD
Prednisone—ALB—Metabolism—SCARB1—kidney cancer	1.25e-05	0.000173	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.24e-05	0.000171	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS1—kidney cancer	1.24e-05	0.000171	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—POMC—kidney cancer	1.22e-05	0.000168	CbGpPWpGaD
Prednisone—ALB—Metabolism—PSMD7—kidney cancer	1.21e-05	0.000167	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.21e-05	0.000167	CbGpPWpGaD
Prednisone—ALB—Hemostasis—RAF1—kidney cancer	1.21e-05	0.000167	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.2e-05	0.000165	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ACHE—kidney cancer	1.19e-05	0.000164	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTT1—kidney cancer	1.19e-05	0.000164	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.16e-05	0.000161	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PGK1—kidney cancer	1.16e-05	0.000161	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTT1—kidney cancer	1.16e-05	0.00016	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ACHE—kidney cancer	1.16e-05	0.00016	CbGpPWpGaD
Prednisone—ALB—Metabolism—BCHE—kidney cancer	1.15e-05	0.000159	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—LDHB—kidney cancer	1.14e-05	0.000157	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC5A5—kidney cancer	1.14e-05	0.000157	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SCARB1—kidney cancer	1.12e-05	0.000155	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS1—kidney cancer	1.11e-05	0.000153	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.000151	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SCARB1—kidney cancer	1.1e-05	0.000151	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PSMD7—kidney cancer	1.09e-05	0.00015	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS1—kidney cancer	1.09e-05	0.00015	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—kidney cancer	1.08e-05	0.00015	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.07e-05	0.000147	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PSMD7—kidney cancer	1.06e-05	0.000147	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.05e-05	0.000144	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—BCHE—kidney cancer	1.03e-05	0.000143	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.02e-05	0.000141	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—BCHE—kidney cancer	1.01e-05	0.000139	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC5A5—kidney cancer	9.97e-06	0.000137	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CA9—kidney cancer	9.9e-06	0.000136	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC2A1—kidney cancer	9.86e-06	0.000136	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—kidney cancer	9.71e-06	0.000134	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC2A1—kidney cancer	9.62e-06	0.000133	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.57e-06	0.000132	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.29e-06	0.000128	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—kidney cancer	9.22e-06	0.000127	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	9.18e-06	0.000127	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTP1—kidney cancer	9.16e-06	0.000126	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK3—kidney cancer	8.72e-06	0.00012	CbGpPWpGaD
Prednisone—ALB—Metabolism—ABCB1—kidney cancer	8.67e-06	0.00012	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—kidney cancer	8.47e-06	0.000117	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTM1—kidney cancer	8.42e-06	0.000116	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CRABP1—kidney cancer	8.42e-06	0.000116	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.34e-06	0.000115	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK1—kidney cancer	8.3e-06	0.000114	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTP1—kidney cancer	8.22e-06	0.000113	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTP1—kidney cancer	8.03e-06	0.000111	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1A1—kidney cancer	7.98e-06	0.00011	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—kidney cancer	7.84e-06	0.000108	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ITPR2—kidney cancer	7.82e-06	0.000108	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ABCB1—kidney cancer	7.78e-06	0.000107	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTM1—kidney cancer	7.56e-06	0.000104	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MAPK3—kidney cancer	7.42e-06	0.000102	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTM1—kidney cancer	7.38e-06	0.000102	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—kidney cancer	7.21e-06	9.95e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—kidney cancer	7.2e-06	9.93e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1A1—kidney cancer	7.16e-06	9.88e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTT1—kidney cancer	7.13e-06	9.84e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ACHE—kidney cancer	7.13e-06	9.84e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1A1—kidney cancer	6.99e-06	9.64e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—kidney cancer	6.97e-06	9.61e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SCARB1—kidney cancer	6.75e-06	9.31e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS1—kidney cancer	6.69e-06	9.22e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.56e-06	9.04e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PSMD7—kidney cancer	6.56e-06	9.04e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—BCHE—kidney cancer	6.22e-06	8.57e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.14e-06	8.47e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—kidney cancer	5.98e-06	8.24e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—POMC—kidney cancer	5.95e-06	8.21e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.93e-06	8.18e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.89e-06	8.12e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—POMC—kidney cancer	5.34e-06	7.37e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—POMC—kidney cancer	5.21e-06	7.19e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTP1—kidney cancer	4.95e-06	6.82e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—kidney cancer	4.75e-06	6.54e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ABCB1—kidney cancer	4.68e-06	6.46e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTM1—kidney cancer	4.54e-06	6.27e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.31e-06	5.94e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—kidney cancer	4.26e-06	5.88e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—kidney cancer	4.16e-06	5.73e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—kidney cancer	4.14e-06	5.71e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—kidney cancer	3.72e-06	5.12e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—kidney cancer	3.63e-06	5e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—POMC—kidney cancer	3.21e-06	4.43e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—kidney cancer	2.92e-06	4.03e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.62e-06	3.61e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—kidney cancer	2.56e-06	3.53e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—kidney cancer	2.56e-06	3.53e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—kidney cancer	2.23e-06	3.08e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.58e-06	2.17e-05	CbGpPWpGaD
